← Eichor
Study identifier: NCT04751760 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

Condition: Allergy and Immunology  ·  Sponsor: University Hospital, Toulouse

PhaseN/A
Planned participants1376
Who can joinAll sexes, 6 Months to 99 Years
Healthy volunteersNo

About this study

The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.

This description comes directly from the study's public registry record.

Talk to the study team

Marine Michelet, MD  ·  33-5 34 55 85 85  ·  michelet.m@chu-toulouse.fr

Always discuss trial participation with your own doctor first.

Locations (2)

University HospitalToulouse, FranceRecruiting
Larrey hospitalToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04751760